These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8554247)

  • 1. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.
    Magid D; Douglas JM; Schwartz JS
    Ann Intern Med; 1996 Feb; 124(4):389-99. PubMed ID: 8554247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.
    Haddix AC; Hillis SD; Kassler WJ
    Sex Transm Dis; 1995; 22(5):274-80. PubMed ID: 7502180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract.
    Craig AP; Kong FY; Yeruva L; Hocking JS; Rank RG; Wilson DP; Donovan B
    BMC Infect Dis; 2015 Apr; 15():200. PubMed ID: 25925662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.
    Genç M; Mårdh A
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):1-7. PubMed ID: 7503471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study).
    Peuchant O; Lhomme E; Krêt M; Ghezzoul B; Roussillon C; Bébéar C; Perry F; de Barbeyrac B;
    Medicine (Baltimore); 2019 Feb; 98(7):e14572. PubMed ID: 30762806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open label comparative study of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore.
    Tan HH; Chan RK
    Singapore Med J; 1999 Aug; 40(8):519-23. PubMed ID: 10572491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis.
    Ossewaarde JM; Plantema FH; Rieffe M; Nawrocki RP; de Vries A; van Loon AM
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):693-7. PubMed ID: 1330565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis.
    Genç M; Mårdh PA
    Pharmacoeconomics; 1997 Sep; 12(3):374-83. PubMed ID: 10170462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments for Chlamydia trachomatis genital infection.
    Weber JT; Johnson RE
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S66-71. PubMed ID: 7795110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy.
    Dimitrijević A; Milosević-Djordjević O; Grujicić D; Arsenijević S
    Mutat Res; 2006 Sep; 608(1):43-8. PubMed ID: 16777475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department.
    Petitta A; Hart SM; Bailey EM
    Pharmacotherapy; 1999 May; 19(5):648-54. PubMed ID: 10331829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective.
    Marra F; Marra CA; Patrick DM
    Can J Infect Dis; 1997 Jul; 8(4):202-8. PubMed ID: 22346517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises.
    Thorpe EM; Stamm WE; Hook EW; Gall SA; Jones RB; Henry K; Whitworth G; Johnson RB
    Genitourin Med; 1996 Apr; 72(2):93-7. PubMed ID: 8698374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
    Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in the treatment of rectogenital
    Hammerschlag MR; Sharma R
    Expert Rev Anti Infect Ther; 2021 Apr; 19(4):487-493. PubMed ID: 33034227
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.